1. Home
  2. BSRR vs RLMD Comparison

BSRR vs RLMD Comparison

Compare BSRR & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

N/A

Current Price

$40.71

Market Cap

532.1M

Sector

Finance

ML Signal

N/A

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

N/A

Current Price

$4.50

Market Cap

461.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSRR
RLMD
Founded
1977
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
532.1M
461.9M
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
BSRR
RLMD
Price
$40.71
$4.50
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$37.00
$12.40
AVG Volume (30 Days)
42.3K
1.1M
Earning Date
04-27-2026
05-08-2026
Dividend Yield
2.93%
N/A
EPS Growth
10.28
45.28
EPS
1.72
N/A
Revenue
N/A
$13,070.00
Revenue This Year
$11.74
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
$23.68
N/A
Revenue Growth
N/A
154.83
52 Week Low
$26.49
$1.45
52 Week High
$43.13
$8.00

Technical Indicators

Market Signals
Indicator
BSRR
RLMD
Relative Strength Index (RSI) 53.75 45.12
Support Level $39.66 $4.29
Resistance Level $41.28 $4.92
Average True Range (ATR) 0.69 0.19
MACD 0.11 0.04
Stochastic Oscillator 82.08 66.21

Price Performance

Historical Comparison
BSRR
RLMD

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. It offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: